It is now well established that the cytokine environment influences the activation, differentiation, proliferation and death of T lymphocytes during the primary response to antigen. Using an in vitro model, we investigated the influence of IL-4, added at the onset of TCR stimulation, on phenotypic and functional markers of naive CD8
Introduction
Optimal T lymphocyte activation is subsequent to the orchestrated interaction of several parameters including the strength and duration of TCR stimulation as well as the presence of co-stimulatory signals (1) . Moreover, the cytokine environment during T cell activation influences T cell proliferation, differentiation and survival (2, 3) . The influence of cytokines is illustrated by the polarization of recently activated CD4 + T cells into Th1 or Th2 effector cells in the presence of specific cytokines, namely IL-12, IL-18 or IFN-c for Th1 and IL-4, -5, -6, -10 and -13 for Th2 differentiation (4) .
IL-4 is a multifunctional cytokine involved in the regulation of immune responses. Initially recognized for its ability to support the growth and differentiation of B lymphocytes (5, 6) , IL-4 is now known to have pleiotropic effects on different cells of the immune system (7, 8) . It is well described that IL-4 induces de novo expression of type 2 cytokines in CD8 + T cells, but the evidence for an effect on the development of cytolytic properties is conflicting. IL-4 has been reported to enhance, reduce or have no effect on the ability of CD8 + T cells to exert cytotoxic functions and to mediate antigen clearance in various models (9) (10) (11) (12) (13) (14) (15) . Since antigen clearance in these models might be dependent on different immune functions and because IL-4 may affect various cell types involved in the immune response, the direct effect of IL-4 on CD8 + T cell function is difficult to assess in vivo. Additionally, little is known about the effect of IL-4 on other parameters associated with T cell activation. Morris and colleagues have reported that IL-4 could suppress CD4 + T cell activation in mice, as demonstrated by inhibition of CD25 and cytokine gene expression (16) . In contrast, a recent in vivo study showed that IL-4 is required for the development of a protective CD8 + T cell response against malaria (17) .
Several reports have shown that IL-4 is endowed with antiapoptotic properties. For example, it has been demonstrated that IL-4 prevents cell death by neglect of resting T cells in mice (18) and of naive B lymphocytes in humans (19, 20) . In addition, it can also promote B cell survival following Ig crosslinking (21) and renders activated B cells insensitive to apoptosis mediated by Fas ligation (22) .
In this report, we demonstrate that IL-4 prevents activationinduced cell death (AICD) in purified naive CD8 + T cells in vitro. Addition of IL-4 during TCR stimulation led to the sustained expression of the survival-related protein Bcl-2 by CD8 + T cells which may explain, at least in part, their resistance to AICD. Interestingly, we show that CD3 crosslinking in the presence of IL-4 promotes the development of a CD8 + T cell sub-population that proliferates normally but which does not up-regulate CD25 expression and fails to express high levels of Granzyme B (GrB). Overall, our results strongly suggest that IL-4 directly affects the fate of naive CD8 + T cells following TCR-mediated stimulation. Isolation, culture and activation of naive CD8 + T cells
Methods

Reagents and antibodies
PBMCs from healthy blood donors were isolated by FicollHyPaque (Pharmacia, Uppsala, Sweden) density gradient. PBMCs were stained with Cy-chrome-labeled anti-CD8 and FITC-labeled anti-CD45RA and sorted using a FACSVantage cell sorter (BD Biosciences, Mountain View, CA, USA) to obtain a pure naive CD8 + CD45RA + population. The purity of the sorted cell population was consistently >97%, as measured by flow cytometry. For some experiments, cells were labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE) (Molecular Probes, Eugene, OR, USA) as previously described by Lyons and Parish (23) . Cells were seeded in 96-well round-bottom plates (Falcon, Oxnard, CA, USA) at a density of 2.5 3 10 5 cells ml ÿ1 and cultured in RPMI 1640 supplemented with 2 mM glutamine, 10% heat-inactivated FCS, 100 U ml ÿ1 penicillin and 0.1 mg ml ÿ1 streptomycin. Naive CD8 + T cells were stimulated using plate-bound anti-CD3 (OKT3, 2 lg ml ÿ1 ) and anti-CD28 (1 lg ml ÿ1 ). In some experiment (specified in the figure legends), T cells were cocultured with irradiated autologous PBMCs (1.25 3 10 5 cells ml ÿ1 ) as feeder cells. Recombinant cytokines were added at the time of cell seeding.
Induction and detection of cell death
Naive CD8 + T cells were activated for 5 days, as described above. After the first stimulation, cells were collected and transferred into anti-CD3-coated wells for re-stimulation. Two to four days after the second stimulation, apoptotic cells were detected using Annexin-V and propidium iodide (PI) labeling according to the manufacturer's protocol (Biosource 
Western blot analysis
Cells were washed twice with PBS and lysed in a buffer containing 2% RIPA, 1% DOC and protease inhibitors (aprotinin, leupeptin, and pepstatin at a final concentration of 1 lg ml ÿ1 ). Protein concentration was calculated using the standard bicinchoninic acid assay (Pierce, Rockford, IL, USA) according to the manufacturer's protocol. Proteins from total cell extracts (20 lg) were separated on 12% polyacrylamide slab minigels and electrotransfered onto polyvinylidene difluoride (PVDF) membranes (Roche, Indianapolis, IN, USA). Membranes were pre-incubated for 1 h at room temperature in PBS containing 0.2% (v/v) Tween 20 and 2% (w/v) low-fat milk powder. Following transfer, membranes were incubated overnight at 4°C with either a monoclonal mouse anti-human Bcl-2 antibody (1:1000, Clone 124, Dako Corp., Copenhagen, Denmark) or a monoclonal mouse anti-human GrB antibody (1:500, clone 2C5, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). Detection of the immune complexes was performed using HRP-conjugated goat anti-mouse Ig antibodies (Bio-Rad Laboratories Inc., Richmond, CA, USA). After 1 h of incubation at room temperature, HRP activity was detected using an enhanced chemiluminescence detection procedure (ECL-plus detection system, Amersham Biosciences, Buckinghamshire, UK) and visualized by exposure to Kodak X-Omat AR film (Eastman Kodak Co., Rochester, NY, USA).
Results
IL-4 protects naive CD8 + T cells from AICD
To determine whether IL-4 affects the susceptibility of CD8 + T cells to undergo AICD, we developed an in vitro AICD model 828 IL-4 prevents AICD of CD8 + T cells driven by repeated TCR stimulation of naive CD8 + T cells. Naive CD8 + T cells were isolated by cell sorting from fresh PBMCs according to the expression of CD8 and CD45RA. Additional flow cytometry analyses showed that a large fraction of this sub-population expressed CD62L (87%), CD27 (92%) and CD28 (95%). Sorted cells expressed neither CD25 nor CD45RO (data not shown), further confirming the naive phenotype of these cells. Based on this phenotype, these cells meet the criteria of resting naive T cells (24, 25) . Naive CD8 + T cells were initially activated using plate-coated anti-CD3 and anti-CD28 antibodies in the presence of IL-2 alone or IL-2 in combination with IL-4. After 3 days of culture, cells were re-stimulated for an additional 48 h using coated anti-CD3. The proportion of cells that underwent AICD was quantified based on Annexin-V-FITC and PI labeling. Figure  1 (A) and (B) show that, in the presence of IL-2 alone,~30% of the cell population underwent apoptosis after the second TCR stimulation. Interestingly, when IL-4 was added to the culture media, the percentage of apoptotic cells consistently dropped below 12% (n = 5). Moreover, it is worth noticing that the proportion of CD8 + T cell undergoing spontaneous apoptosis or passive cell death (i.e. in the absence of re-stimulation) is also 2-fold lower in the presence of IL-2 and IL-4 as compared with IL-2 alone. These results indicate that IL-4, added at the ) and anti-CD28 (1 lg ml ÿ1 ). IL-2 (100 U ml ÿ1 ) and IL-4 (500 U ml ÿ1 ) were added at the beginning of cell culture. After 5 days of stimulation, cells were re-stimulated for 48 h using plate-coated anti-CD3 (2 lg ml 
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IL-4 interferes with naive CD8 + T cell activation and differentiation
Activation of naive T cells is characterized by changes in surface expression of several molecules such as CD45RA, CD25 (the alpha chain of the high affinity receptor for IL-2) or Fas/CD95 (26, 27) . To determine the impact of IL-4 on phenotypic changes associated to T cell activation, naive CD8 + T cells were activated using anti-CD3 + anti-CD28 antibodies in the presence of IL-2 alone or in combination with IL-4. After 3 days of stimulation, the expression of activation markers was assessed by flow cytometry. For these experiments, naive CD8 + T cells were co-cultured with irradiated autologous PBMCs to ensure the provision of optimal costimulatory signals. As irradiated PBMCs die rapidly in culture, they can be excluded from the analysis by gating on the live lymphocyte population, based on forward-and side-scatter profiles. As shown in Fig. 2 (A) (n = 3), stimulation of naive CD8 + T cells in the presence of IL-2 led to up-regulation of CD25 and Fas expression and to the down-regulation of CD45RA expression. However, addition of exogenous IL-4 to the TCR trigger led to a significantly reduced number of activated cells that had up-regulated CD25 and Fas, while a higher proportion of cells maintained CD45RA expression. The extent to which IL-4 modulates the frequency of cell expressing these markers varied from one donor to another but typically ranged from 20 to 60% for CD25, from 20 to 50% for CD45RA and from 20 to 30% for Fas. The proliferation of naive CD8 + T cells after TCR triggering was measured using [ 3 H]TdR incorporation. Results presented in Fig. 2(B) show that IL-4 treatment slightly decreases anti-CD3-induced proliferation of the bulk naive CD8 + T cell population. However, it is impossible to determine using this assay if the diminished [ 3 H]TdR incorporation is due to a weak inhibition of the proliferation of the whole T cell population or to a selective block in the proliferation of a given cell sub-population. Taken together, these observations suggest that the presence of IL-4 at the time of TCR stimulation affects several parameters of naive CD8 + T cells activation.
IL-4 promotes the development of a sub-population that proliferates but exhibits a non-activated phenotype following TCR stimulation
The IL-4-induced partial inhibition of normal CD8 + T cell activation can result either from the defective TCR engagement after CD3 cross-linking or from a defect in the acquisition of specific features of T cell activation (such as up-or downregulation of specific markers), without affecting others such as cell proliferation. To address this issue, we simultaneously monitored the proliferation and the acquisition of the activation marker CD25 by naive CD8 + T cells stimulated in the presence or absence of exogenous IL-4. CFSE-labeled naive CD8 + T cells were activated for 3 days by CD3 cross-linking and the cell-surface expression of CD25 was quantified by flow cytometry. Results (Fig. 3, see inset) indicate that after 3 days of TCR stimulation, cells had undergone between one and five cycles of proliferation, as measured by CFSE dilution.
Concomitantly, we observed an increase in CD25 surface expression in dividing cells; CD25 was up-regulated at the onset of the first cell division and remained constantly high until the fifth cell division. Cells that remain CFSE high and CD25 ÿ most likely represent resting cells that have not been stimulated. We consistently observed that~5% of the proliferating cells failed to up-regulate CD25 in the presence of exogenous IL-2 alone. This proportion increased to~20% when exogenous IL-2 and IL-4 were added simultaneously (Fig. 3, lower panel) . Interestingly, for both IL-2-and IL-2 + IL-4-treated cells, the proliferating CD25 neg cell sub-population were found in cells that underwent only one division, as well as in cells that have achieved up to six rounds of cell proliferation, strongly suggesting that the absence of CD25 at the surface of these cells is not due to a decrease in its expression during proliferation. Moreover, the addition of exogenous IL-4 alone during TCR stimulation leads to an increase in the proportion of CFSE low and CD25 ÿ as compared with cells activated in the absence of any exogenous cytokines (Fig. 3, upper panel) . Our results suggest that IL-4 promotes the development of a previously uncharacterized CD8 + T cell sub-population that proliferates normally upon TCR stimulation, but which fails to exhibit a 'typical' activated phenotype, as defined by the upregulation of CD25 expression.
The biological functions of IL-4 are achieved through the heterodimerization of the IL-4Ra chain and the gamma common chain (cc), first identified as a component of the IL-2R (7). The cc chain is also shared by other cytokine receptors (IL-7R and IL-15R), whereas the IL-4Ra chain also functions as a component of the IL-13R. We therefore examined if one of these cytokines could also promote the generation of proliferating CD25 neg CD8 + T cells, as observed in the presence of IL-4. CFSE-labeled naive CD8 + T cells were TCR stimulated in the presence of exogenous IL-2. IL-4, IL-7, IL-13 or IL-15 was also added at the onset of stimulation. After 3 days, cells were stained with a mAb directed against CD25 and the proportion of CFSE low CD25 ÿ cells within the CD8 + T cell population was determined by flow cytometry (Fig. 4) . In contrast to IL-4, addition of exogenous IL-7, IL-13 or IL-15 does not significantly alter the frequency of CFSE low CD25 ÿ cell population as compared with addition of IL-2 alone, evidencing the unique effect of IL-4 on naive CD8 + T cell activation. 
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IL-4 prevents Bcl-2 down-regulation induced by CD3 cross-linking
Proteins from the Bcl-2 family, endowed with either anti-or proapoptotic functions, are well known for their ability to regulate susceptibility to apoptosis in many cell types (28, 29) . IL-4 has been shown to induce the up-regulation of Bcl-2 in murine T cells (18) as well as in human B cells (30) . Therefore, we tested the impact of addition of IL-4 on the level of expression of Bcl-2 in anti-CD3-activated naive CD8 + T cells cultured with IL-2 and IL-4, either alone or in combination. After 3 days of stimulation, cells were lysed and the cell lysates were electrophoresed in SDS polyacrylamide gel. Proteins were then transferred onto PVDF membrane and probed with antibodies directed against Bcl-2 (Fig. 5) . Non-activated naive CD8 + T cells contain high levels of Bcl-2 (lane 2). As previously described (31), CD3 cross-linking led to a sharp decrease in Bcl-2 expression level, which became barely detectable (lane 3). Addition of exogenous IL-2 at the onset of T cell priming did not prevent Bcl-2 down-regulation (lane 5). In contrast, CD8 + T cells activated in the presence of IL-4 (either alone or in combination with IL-2) continued to express Bcl-2 (lane 4 and 6), albeit at lower levels than non-activated cells.
These results demonstrate that IL-4 partially prevents the decay of Bcl-2 expression following TCR-mediated activation of naive CD8 + T cells, which might explain, at least in part, the lower susceptibility to apoptosis of CD8 + T cells activated in the presence of IL-4.
IL-4 inhibits GrB up-regulation following activation of naive CD8 + T cells
Differentiation of naive CD8 + T cells into effector cells is characterized by the acquisition of cytolytic functions (32) . As previously mentioned, IL-4 has been reported to exert divergent effects on the acquisition of cytolytic properties in CD8 + T cells (9) (10) (11) (12) (13) (14) (15) . To investigate the role of IL-4 on the development of these functions following CD8 + T cell activation in our model, we analyzed the level of expression of GrB, a potent apoptosis-inducing protease of CTLs (33) , in cells activated in the presence of IL-2 and/or IL-4 (Fig. 6) ) and anti-CD28 (1 lg ml ÿ1 ) in presence of IL-2 (100 U ml ÿ1 ) and/or IL-4 (500 U ml ÿ1 ). After 3 days of stimulation, cells were collected, lysed and 20 lg of total cell extract was subjected to immunoblot using an anti-GrB antibody. The membrane was subsequently stripped and re-blotted with an anti-actin antibody. Nonstimulated naive (CD45RA + ) and memory (CD45RO We then analyzed GrB protein expression by intracellular flow cytometry to determine if the CFSE low CD25 ÿ cells generated in the presence of IL-4 express lower levels of GrB. Fig. 7(A) shows that 80% of the CFSE low CD25 + are GrB positive when cells proliferate in the presence of IL-2 alone or IL-2 + IL-4, while the proportion of GrB-positive cells in the CFSE high (cells that do not proliferate) is negligible. In contrast, within the CFSE low CD25 ÿ compartment, only 35% of the cells are GrB positive (Fig. 7A and B) . These results show that the inhibition of GrB up-regulation, in response to IL-4, is mainly observed within the CFSE low CD25 ÿ sub-population, indicating that CD8 + T cell activation in the presence of IL-4 will lead to the generation of cells that are able to proliferate while expressing low levels of the cytotoxic effector molecule, GrB. + T cells in the presence of IL-4 leads to the generation of a sub-population of activated cells that do not express CD25 (but express similar level of other surface markers including OX40, CD27 and CD62L as compared with the activated CD25 + compartment) and contain no or low level of GrB, suggesting an inability to exert cytotoxic function.
Discussion
It is well described that cytokines have the ability to profoundly influence T cell development and differentiation, both in vitro and in vivo (34) . In this report, we demonstrate that exposure to IL-4 during primary activation of CD8 + T cells (i) partially protects cells from AICD and (ii) promotes the development of a sub-population of CD8 + T cells that proliferate normally but that does not up-regulate CD25 and GrB expression.
We provide two possible mechanisms by which IL-4 could protect activated CD8 + Tcells from apoptosis. which IL-4 promotes the expression of Bcl-2 is unclear but most probably involves the activation, through the IL-4R signaling pathway, of Akt/PKB, which is known to regulate the expression of Bcl-2 family proteins including Bcl-2 (7). Experimental evidence strongly suggests that a pathway involving Bcl-2 proteins is directly involved in protecting T cells from apoptosis. For example, in vivo experiments have shown a decrease in the levels of Bcl-2 as T cells undergo apoptosis (36) . Moreover, the over-expression of Bcl-2 increases T cell responses to viral challenge, most likely by preventing the death of activated T cells following pathogen clearance (37) . Therefore, our results strongly suggest that IL-4, by inhibiting Fas expression and maintaining Bcl-2 expression following T cell activation, controls CD8 + T cell longevity and that it might be an important factor involved in the generation of long-term memory CD8 + T cells. Supporting this hypothesis, it was demonstrated that naive CD8 + T cells exposed to exogenous IL-4 for a short period during in vitro TCR stimulation have an increased ability to survive and to generate long-term memory T cells following in vivo adoptive transfer (38) .
Evidence supporting the inhibitory effect of IL-4 on the acquisition of cytotoxic functions by CD8 + T cells has been provided by studies using various in vivo models. It was shown that antigen-specific CD8 + T cells from IL-4-deficient mice display superior cytolytic activities as compared with T cells from IL-4+/+ mice (14) . In contrast, over-expression of IL-4 during the course of an immune response favors the development of antigen-specific CTLs having diminished perforin/ granzyme-mediated cytotoxicity (14, 39, 40) . The marked IL-4-mediated decrease in GrB expression by a sub-population of CD8 + T cells (Fig. 6 ) strongly suggests that these cells have a limited cytolytic potential because of the central role of GrB in granule-mediated cytolysis (41) . Supporting this possibility, Kienzle and colleagues have demonstrated, using a murine T cell clonal culture system, that TCR stimulation of naive CD8 + T cells in the presence of IL-4 for several days induces a subpopulation of CD8 + T cells expressing low levels of perforin and Granzyme mRNA that possess limited cytolytic functions (11, 42) . Similar results were previously reported by another group using a different experimental system (43) . Interestingly, in these three studies, the decrease in cytolytic functions was associated with a marked down-regulation of CD8 expression at the surface of the T cells, a phenomenon that was not observed in our experiments. This discrepancy could be due to intrinsic differences between mouse and human T cells or to differences in the model/experimental settings used to perform the experiments, most notably the length and duration of the cultures. However, we demonstrate that activated CD8 + T cells that fail to induce GrB expression also fail to up-regulate CD25, a marker normally expressed by T cells following TCR stimulation. Interestingly, the IL-4-induced loss of CD25 expression at the surface of these cells was not due to an abortive stimulation since these cells were induced to proliferate at levels comparable to those of CD25 + CD8 + T cells (at least up to six rounds of cell proliferation), but most probably due to an ability to induce the pathway leading to transcription of the CD25 gene or to the inhibition of cellsurface expression of CD25. Further studies will be required to test whether other activation pathways are modulated in CD8 + T cells activated in the presence of IL-4.
There is mounting evidence that distinct subsets of CD8 + T cells having different functional properties (termed Tc1 and Tc2), analogous to their CD4 counterparts (T h 1 and T h 2), exist in both rodents and humans. The differentiation of these subsets appears to be mainly influenced by the presence of different cytokines in the T cell microenvironment, with IFN-c and IL-12 promoting the development of Tc1 cells and IL-4 inducing the differentiation into Tc2 cells (44, 45) . Vukmanovic-Stejic et al. have shown that Tc2 T cell clones (i.e. generated in the presence of IL-4) are more resistant to AICD and express higher levels of CD40L, leading to the hypothesis that these cells could provide help to B cells (46, 47) . Therefore, addition of exogenous IL-4 during CD8 + T cell stimulation in our system probably promotes the differentiation of CD8 + T cells into Tc2-like cells possessing distinct functional properties as compared with 'classical' type I CTLs. By virtue of their diminished cytolytic functions and increased resistance to AICD, these Tc2 cells might play a regulatory role or induce other immune defense mechanisms during the immune response, as opposed to the direct killing of target cells mediated by Tc1 cells, thereby contributing to the diversity of effector functions during an immune response. Further studies on IL-4-mediated CD8 + T cell differentiation should lead to a deeper understanding of the function of this AICD-resistant, low cytolytic CD8 + CD25
ÿ T cell sub-population during the immune response.
